| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2085c1b330af2b9b7d396ba7cd594a86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_790110ba53d6d143fd2c7f2ca50abbee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c66017834d2702aaf09a7126ac8e80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8ec5f5eaeaf77dd2f76dc8449766d25 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c2ad373c1351c824dd05f643934e4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b077f92e9acf5058f4bc2d17845096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b89d5e723f45af85c03aa1eccdd618a3 |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012078591-A1 |
| titleOfInvention |
Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients |
| abstract |
The subject invention provides methods for reducing or inhibiting progression of the level of fatigue in a multiple sclerosis human patient, for improving or inhibiting deterioration of the functional status of a multiple sclerosis human patient, and for improving or inhibiting deterioration of the general health of a multiple sclerosis human patient, comprising orally administering to the human patient laquinimod or a pharmaceutically acceptable salt thereof. The subject invention also provides a method for providing neuroprotection to a human subject, the method comprising orally administering to the human subject laquinimod or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015109083-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014052933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654140-B2 |
| priorityDate |
2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |